Combining lenalidomide with IL-2 family of cytokines enhances activating receptor and perforin/granzyme expression in NK cells
These data provide a rationale for the combination of lenalidomide with IL-2 family of cytokines to enhance the effectiveness of NK cells.
Authors
- Nicole Fortenbery
- Alexandra Calescibetta
- Erika Adriana Eksioglu (ORCID: https://orcid.org/0000-0003-4458-7192)
- Kenneth L. Wright (ORCID: https://orcid.org/0000-0003-2951-5748)
- Thu Le Trinh (ORCID: https://orcid.org/0000-0001-8517-4891)
- Nhan Tu
- Sean Christiansen
- Grace Ward (ORCID: https://orcid.org/0000-0003-4404-7727)
- Tiffany N. Razabdouski (ORCID: https://orcid.org/0009-0008-5666-8575)
- Pingyan Cheng
- Sheng Wei
- Xianghong Chen
- Robert Dalton
- Jinghong Liu
- Annelise J. Glode
Institutions
- Moffitt Cancer Center (US)
Publication Details
- Journal
- PLoS ONE
- Published
- 2026-03-12
- DOI
- https://doi.org/10.1371/journal.pone.0344471
- Primary Topic
- Immune Cell Function and Interaction
- Type
- article
- Field-Weighted Citation Impact
- 0.00